Block, Inc. Class A XYZ 深 沪
等待开盘 05-14 09:30:00 美东时间
71.03
-1.090
-1.51%
华盛通- 最 高71.24
- 今 开71.13
- 成交量 194.32万股
- 最 低 68.72
- 昨 收 72.12
- 总市值 423.09亿
- 52周最高 82.50
- 市盈率 静 33.78
- 换手率 0.33%
- 52周最低 48.21
- 委 比 51.52%
- 总股本 5.96亿
- 历史最高 289.23
- 量 比 0.62
- 振 幅 3.49%
- 历史最低 8.061
- 每 手 1
- 风险率 7.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Block Stock Is Falling Monday: What's Going On?
Block is trading lower Monday afternoon as traders digest a fresh bullish take on the company's post-earnings setup.
05-12 04:00
This Block Analyst Remains Bullish On Earnings Power Inflection, Improving Execution
Block reported strong Q1 and raised guidance. Bank of America sees a constructive start to the year and maintains Buy rating with $100 PT.
05-12 00:19
This Block Analyst Remains Bullish On Earnings Power Inflection, Improving Execution
Shares of Block Inc (NYSE:XYZ) slipped in early trading this morning after clim...
05-12 00:19
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Needham Maintains Buy on Block, Raises Price Target to $95
Needham analyst Mayank Tandon maintains Block (NYSE:XYZ) with a Buy and raises the price target from $90 to $95.
05-08 20:17
Block Sees FY2026 Adj EPS $3.85 vs $3.71 Est
Block (NYSE:XYZ) is looking for FY2026 Adj EPS of $3.85 vs $3.71 analyst estimate..
05-08 07:32
Block Sees Q2 Adj EPS $0.86 vs $0.82 Est
Block (NYSE:XYZ) is looking for Q2 Adj EPS of $0.86 vs $0.82 analyst estimate..
05-08 07:32
财报速睇 | Block, Inc. Class A 2026财年Q1营收60.57亿美元，同比增长4.9%；归母净利润亏损3.09亿美元，由盈转亏
华盛资讯5月8日讯，Block, Inc. Class A公布2026财年Q1业绩，公司Q1营收60.57亿美元，同比增长4.9%，归母净利润亏损3.09亿美元，由盈转亏。
05-08 07:07
